Sheetal Shroff MD

Neurology•Houston, TX

Neuromuscular Medicine

Neuromuscular fellowship program director Assistant Professor of Clinical Neurology Houston Methodist Neurological Institute Weill Cornell Medical College

Join to View Full Profile

6560 Fannin StreetSuite 802Houston, TX 77030
Phone+1 713-363-7310
Fax+1 713-790-2059

Summary

Sheetal Shroff, MD, is a Neurologist based in Houston, TX, with a subspecialty in Neuromuscular Medicine. She completed her education and residencies at the University of Texas Medical Branch Hospitals and her fellowship at Methodist Hospital in Houston. She is presently employed as an Assistant Professor at Houston Methodist Hospital since 2014. Her areas of expertise include treatment of amyotrophic lateral sclerosis, myasthenia gravis, electromyography, muscle biopsy, and myotonic dystrophy. She is also an accomplished researcher and author, with several publications cited multiple times in her field. Additionally, she has participated in several clinical trials.

Education & Training

Houston Methodist Hospital (Medical Center)Fellowship, Neuromuscular Medicine (Neurology), 2014 - 2015
University of Texas Medical Branch HospitalsResidency, Neurology, 2011 - 2014
University of Texas Medical Branch HospitalsResidency, Internal Medicine, 2010 - 2011
Kempegowda Institute of Medical ScienceClass of 2007

Certifications & Licensure

TX State Medical License 2014 - 2026
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Neuromuscular Medicine
American Board of Electridiagnostic MedicineABEM (EMG/NCS)

Clinical Trials

HEALEY ALS Platform Trial - Master Protocol Start of enrollment: 2020 Jul 14
Active, not recruiting
Phase 2, Phase 3
HEALEY ALS Platform Trial - Regimen G DNL343 Start of enrollment: 2023 May 24
COMPLETED
PHASE2, PHASE3
HEALEY ALS Platform Trial - Regimen F ABBV-CLS-7262 Start of enrollment: 2023 Mar 23
COMPLETED
PHASE2, PHASE3
HEALEY ALS Platform Trial - Regimen E SLS-005 - Trehalose Start of enrollment: 2022 Feb 21
COMPLETED
PHASE2, PHASE3
HEALEY ALS Platform Trial - Regimen D Pridopidine Start of enrollment: 2020 Dec 18
Completed
Phase 2, Phase 3
HEALEY ALS Platform Trial - Regimen C CNM-Au8 Start of enrollment: 2020 Jul 30
Completed
Phase 2, Phase 3
HEALEY ALS Platform Trial - Regimen A Zilucoplan Start of enrollment: 2020 Jul 29
Completed
Phase 2, Phase 3
HEALEY ALS Platform Trial - Regimen B Verdiperstat Start of enrollment: 2020 Jul 28
Completed
Phase 2, Phase 3
Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG) Start of enrollment: 2019 Dec 04
Recruiting
Phase 2
A Study to Evaluate Rozanolixizumab in Study Participants With Generalized Myasthenia Gravis Start of enrollment: 2021 Feb 03
Completed
Phase 3
Phase 3 Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants With Generalized Myasthenia Gravis Start of enrollment: 2022 Jun 27
ACTIVE_NOT_RECRUITING
PHASE3
Study of Safety and Proof of the Mechanism of BLZ945 in ALS Patients Start of enrollment: 2019 Dec 30
TERMINATED
PHASE2
RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis Start of enrollment: 2024 Dec 17
RECRUITING
PHASE1, PHASE2
Study of ALXN2220 Versus Placebo in Adults With ATTR-CM Start of enrollment: 2024 Jan 11
RECRUITING
PHASE3
MAGNITUDE: a Phase 3 Study of NTLA-2001 in Participants with Transthyretin Amyloidosis with Cardiomyopathy (ATTR-CM) Start of enrollment: 2023 Dec 13
RECRUITING
PHASE3
Join now to see all

Publications & Presentations

PubMed

Verdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial.
, Jinsy Andrews, Sabrina Paganoni, Eric A Macklin, Lori B Chibnik
JAMA Neurology. 2025-02-17
2 citations
CNM-Au8 in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.
, James D Berry, Nicholas J Maragakis, Eric A Macklin, Lori B Chibnik
JAMA. 2025-02-17
Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.
, Jeremy M Shefner, Björn Oskarsson, Eric A Macklin, Lori B Chibnik
JAMA. 2025-02-17

Press Mentions

Rare Side Effect of Flu Puts Young Men at RiskMarch 1st, 2018

Professional Memberships

Other Languages

Kannada, Hindi